Trending

sickle cell

GBT heads to FDA with sickle cell drug voxelotor

GBT heads to FDA with sickle cell drug voxelotor

Global Blood Therapeutics (GBT) has persuaded the FDA to accept biomarker data from a phase III trial of

X

GBT heads to FDA with sickle cell drug voxelotor

https://pharmaphorum.com/news/gbt-heads-to-fda-with-sickle-cell-drug-voxelotor/

Novartis drug cuts serious complications in sickle cell disease

Novartis drug cuts serious complications in sickle cell disease

Novartis’ developmental sickle cell disease drug crizanlizumab cut occurrences of a serious complication of the disease that can

X

Novartis drug cuts serious complications in sickle cell disease

https://pharmaphorum.com/news/novartis-drug-cuts-serious-complications-in-sickle-cell-disease/

Novartis buys sickle cell biotech Selexys

Novartis buys sickle cell biotech Selexys

Swiss pharma takes option on US biotech.

X

Novartis buys sickle cell biotech Selexys

https://pharmaphorum.com/news/novartis-buys-us-biotech-selexys/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com